Megola, Inc. announced the successful completion of its Pilot Scale-up Field Testing with its patent-pending Odor Control (SAPs) for Baby Diapers, Adult Incontinence and Feminine Hygiene Products. The odor control personal hygiene products were provided to a group of incontinent human volunteers in the USA. Skin irritation testing conducted by an independent contractor according to an FDA approved protocol is underway, with results due shortly.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0069 USD | 0.00% | -9.21% | +187.50% |
1st Jan change | Capi. | |
---|---|---|
+187.50% | 2.01M | |
+12.80% | 26.04B | |
-5.86% | 16.74B | |
-17.56% | 6.44B | |
+9.05% | 6.16B | |
-1.58% | 3.2B | |
-2.83% | 2.3B | |
-9.88% | 1.97B | |
+27.31% | 955M | |
-0.44% | 646M |
- Stock Market
- Equities
- MGON Stock
- News Megola, Inc.
- Megola, Inc. Completes Pilot Scale-Up Field Testing with its Patent-Pending Odor Control for Baby Diapers, Adult Incontinence and Feminine Hygiene Products